KOREA PHARMA to issue Convertible Bonds
한국파마
032300
Signal Score
Historical Avg Return (5d)
+0.26%
Data Coverage
100%n=2457
Risk-adjusted indicator based on 2457 historical DART filings. For informational purposes only — not investment advice.
Financial Impact
NEUTRAL
Key Numbers
- • Surface Interest Rate: 0.0%
- • Maturity Interest Rate: 0.0%
- • Call Option Exercise Rate: 0.1% annual compound interest
- • Call Option Limit: 40% of initial subscription amount per bondholder
AI Analysis Summary
KOREA PHARMA Co., Ltd. has decided to issue convertible bonds with a 0.0% surface and maturity interest rate. The bonds include a put option for bondholders to request early redemption after 30 months from the issuance date, at 100% of the electronic registration amount with 0.0% compound interest. A call option allows the company or its designees to purchase up to 40% of each bondholder's initial subscription amount, with an annual compound interest rate of 0.1%. The specific total amount, conversion price, and number of shares to be issued upon conversion are not disclosed in this report, preventing a full dilution analysis. The purpose of the funds is also not specified. The issuance is to various private investment funds.
How This Event Is Evaluated
Capital Raise Evaluation
Capital raise events are evaluated by estimating dilution pressure, funding purpose, pricing terms, and impact on existing shareholders.
AI is used to interpret disclosures and extract structured data.
Signal scores are generated using event-specific methodologies and quantitative models.
- Potential dilution rate
- Issuance or conversion price
- Funding purpose
- Shareholder value impact
Track Korean Market Signals — Free
Sign up free to access live disclosures, AI analysis, and event filters.
Public Beta · No credit card required
This content is for informational purposes only and does not constitute investment advice. Past signal patterns do not guarantee future results. All data is sourced from public DART filings.